The one thing Ozempic still can’t fix
Vox · L · trust 59/100
GLP-1 drugs promised to usher in a new era of treating obesity as a disease. We could leave behind the anti-fat biases of the past, which blamed obesity on moral failing or personal weakness. Instead, these drugs would allow us to approach it as a medical condition, a complex matrix of genetics and other forces […]
Read the original at Vox →
Open in TruthVane →